TrialEye (London, England)2015

Earlier therapeutic effects associated with high dose (2.0 mg) Ranibizumab for treatment of vascularized pigment epithelial detachments in age-related macular degeneration.

C K Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.